2 Users have not reported any adverse effects compared to harmful steroids
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study
Prebiotic FOS Fiber Natural fiber that serves as food for "good" bacteria in the gut
Artificial flavouring (multi-fruit flavour), sweeteners: sucralose (E955, 24mg/100ml), preservatives: sodium benzoate (E211), Potassium sorbate (E202)
For small, steady progress, it is a sensible first step